ANISHA SARVER: Open Payments
NPI 1336857598 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 58 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $1,374
Food & beverage: $1,374
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 33 | $887 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Lundbeck LLC | 5 | $95 |
| Gilead Sciences, Inc. | 5 | $94 |
| Novo Nordisk Inc | 3 | $59 |
| Antares Pharma, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: APRETUDE, REXULTI, CABENUVA, DOVATO, Ozempic, XYOSTED, PREVNAR 20, HORIZANT.
Industry payments across NY — which companies pay providers there.
